Medtronic PLC Form 4 insider transactions

Director Elizabeth G. Nabel acquired Medtronic plc shares and restricted stock units, increasing her beneficial ownership.

Kevin E. Lofton, a director of Medtronic plc, reported the acquisition of 2,165 ordinary shares at $80.86 per share on April 29, 2024, along with dividend reinvestments.

Gregory P. Lewis, a director at Medtronic plc, acquired 1,821 shares of common stock at a price of $80.86 per share on April 29, 2024.

Director Randall J. Hogan acquired 2,165 ordinary shares and was granted restricted stock units of Medtronic plc on April 29, 2024.

Director Andrea Jo Goldsmith reports acquisition of Medtronic shares through restricted stock units and dividend reinvestment.

Director Lidia Fonseca reported the acquisition of 2,165 ordinary shares and disposal of 55 shares of Medtronic plc.

Director Scott C. Donnelly reports acquisition of Medtronic shares and restricted stock units.

Director Craig Arnold reported acquiring 2,165 ordinary shares of Medtronic plc at $80.86 per share on April 29, 2024, through an award of restricted stock units.

Michael Marinaro, EVP & President, Surgical OU of Medtronic plc, sold 854 ordinary shares at an average price of $83.14 on April 8, 2024.

Medtronic's EVP & President, Surgical OU, Michael Marinaro, reports a transaction involving ordinary shares on March 5, 2024, including shares withheld for tax payments and shares acquired through dividend reinvestment.